Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Type Segment
1.1.2. Application Segment
1.1.3. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Primary Research
1.6. Information or Data Analysis:
1.6.1. Data Analysis Models
1.7. Market Formulation & Validation
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. List of Abbreviations
1.11. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Advancements in proteomics research
3.2.1.2. Rising incidence of chronic diseases
3.2.2. Market Restraint Analysis
3.2.2.1. High cost
3.2.2.2. Data analysis complexity
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. Type Segment Dashboard
4.2. Protein Chip Market Type Movement Analysis
4.3. Protein Chip Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Analytical Microarrays
4.4.1. Analytical microarrays market estimates and forecasts, 2018 – 2030 (USD Million)
4.5. Functional Protein Microarrays
4.5.1. Functional protein microarrays market estimates and forecasts, 2018 – 2030 (USD Million)
4.6. Reverse Phase Protein Microarrays
4.6.1. Reverse phase protein microarrays market estimates and forecasts, 2018 – 2030 (USD Million)
Chapter 5. Application Group Business Analysis
5.1. Application Segment Dashboard
5.2. Protein Chip Market Application Movement Analysis
5.3. Protein Chip Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Antibody Characterization
5.4.1. Antibody characterization market estimates and forecasts, 2018 – 2030 (USD Million)
5.5. Clinical Diagnostics
5.5.1. Clinical diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)
5.6. Proteomics
5.6.1. Proteomics market estimates and forecasts, 2018 – 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts, 2018 – 2030 (USD Million)
Chapter 6. End-use Business Analysis
6.1. End-use Segment Dashboard
6.2. Protein Chip Market End Use Movement Analysis
6.3. Protein Chip Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
6.4. Hospitals & Clinics
6.4.1. Hospitals & clinics market estimates and forecasts, 2018 – 2030 (USD Million)
6.5. Diagnostic Laboratories
6.5.1. Diagnostic laboratories market estimates and forecasts, 2018 – 2030 (USD Million)
6.6. Academic & Research Institutes
6.6.1. Academic & research institutes market estimates and forecasts, 2018 – 2030 (USD Million)
6.7. Pharmaceutical & Biotechnology Companies
6.7.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 – 2030 (USD Million)
Chapter 7. Regional Business Analysis by Type, Application, End Use
7.1. Regional Dashboard
7.2. Market Size & Forecast and Trend Analysis, 2023 & 2030
7.3. North America
7.3.1. North America Protein Chip Market, 2018 – 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. U.S. Protein Chip Market, 2018 – 2030 (USD Million)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Canada Protein Chip Market, 2018 – 2030 (USD Million)
7.4. Europe
7.4.1. Europe Protein Chip Market, 2018 – 2030 (USD Million)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. UK Protein Chip Market, 2018 – 2030 (USD Million)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Germany Protein Chip Market, 2018 – 2030 (USD Million)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. France Protein Chip Market, 2018 – 2030 (USD Million)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Italy Protein Chip Market, 2018 – 2030 (USD Million)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Spain Protein Chip Market, 2018 – 2030 (USD Million)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Denmark Protein Chip Market, 2018 – 2030 (USD Million)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Regulatory Framework
7.4.8.4. Sweden Protein Chip Market, 2018 – 2030 (USD Million)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Competitive Scenario
7.4.9.3. Regulatory Framework
7.4.9.4. Norway Protein Chip Market, 2018 – 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific Protein Chip Market, 2018 – 2030 (USD Million)
7.5.2. Japan
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Japan Protein Chip Market, 2018 – 2030 (USD Million)
7.5.3. China
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. China Protein Chip Market, 2018 – 2030 (USD Million)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. India Protein Chip Market, 2018 – 2030 (USD Million)
7.5.5. Australia
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Australia Protein Chip Market, 2018 – 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. Thailand Protein Chip Market, 2018 – 2030 (USD Million)
7.5.7. South Korea
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. South Korea Protein Chip Market, 2018 – 2030 (USD Million)
7.6. Latin America
7.6.1. Latin America Protein Chip Market, 2018 – 2030 (USD Million)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Brazil Protein Chip Market, 2018 – 2030 (USD Million)
7.6.3. Mexico
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Mexico Protein Chip Market, 2018 – 2030 (USD Million)
7.6.4. Argentina
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Argentina Protein Chip Market, 2018 – 2030 (USD Million)
7.7. MEA
7.7.1. MEA Protein Chip Market, 2018 – 2030 (USD Million)
7.7.2. South Africa
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. South Africa Protein Chip Market, 2018 – 2030 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Saudi Arabia Protein Chip Market, 2018 – 2030 (USD Million)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. UAE Protein Chip Market, 2018 – 2030 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory Framework
7.7.5.4. Kuwait Protein Chip Market, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. Agilent Technologies
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. PerkinElmer
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Bio-Rad Laboratories
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Thermo Fisher Scientific
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Sigma-Aldrich Corporation
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Illumina
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Shimadzu Corporation
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Roche Diagnostics
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. RayBiotech
8.4.9.1. Overview
8.4.9.2. Product Benchmarking
8.4.9.3. Strategic Initiatives
8.4.10. Danaher
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
|